scispace - formally typeset
Open AccessJournal ArticleDOI

Cannabis sativa: The Plant of the Thousand and One Molecules

TLDR
Prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.
Abstract
Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence of interest because of its multi-purpose applications: it is indeed a treasure trove of phytochemicals and a rich source of both cellulosic and woody fibers. Equally highly interested in this plant are the pharmaceutical and construction sectors, since its metabolites show potent bioactivities on human health and its outer and inner stem tissues can be used to make bioplastics and concrete-like material, respectively. In this review, the rich spectrum of hemp phytochemicals is discussed by putting a special emphasis on molecules of industrial interest, including cannabinoids, terpenes and phenolic compounds, and their biosynthetic routes. Cannabinoids represent the most studied group of compounds, mainly due to their wide range of pharmaceutical effects in humans, including psychotropic activities. The therapeutic and commercial interests of some terpenes and phenolic compounds, and in particular stilbenoids and lignans, are also highlighted in view of the most recent literature data. Biotechnological avenues to enhance the production and bioactivity of hemp secondary metabolites are proposed by discussing the power of plant genetic engineering and tissue culture. In particular two systems are reviewed, i.e., cell suspension and hairy root cultures. Additionally, an entire section is devoted to hemp trichomes, in the light of their importance as phytochemical factories. Ultimately, prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Cannabidiol: State of the art and new challenges for therapeutic applications

TL;DR: This review highlights the pharmacological activities of CBD, its cannabinoid receptor-dependent and -independent action, its biological effects focusing on immunomodulation, angiogenetic properties, and modulation of neuronal and cardiovascular function, and the therapeutic potential of cannabidiol.
Journal ArticleDOI

Silicon and Plants: Current Knowledge and Technological Perspectives.

TL;DR: The study provides perspectives on the use of Si to increase the yield of fiber crops and to improve the thermal stability and tensile strength of natural fibers and to modify/improve the physical parameters of plant fibers.
Journal ArticleDOI

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.

TL;DR: A deeper involvement of phytocannabinoids (the key compounds in C. sativa) in several others central and peripheral pathophysiological mechanisms such as food intake, inflammation, pain, colitis, sleep disorders, neurological and psychiatric illness is suggested.
Journal ArticleDOI

Reactive oxygen species and heavy metal stress in plants: Impact on the cell wall and secondary metabolism

TL;DR: In this paper, the effects of heavy metal-induced reactive oxygen species (ROS) on plant cell wall-related processes and the stimulatory/inhibitory effects of ROS on plant secondary metabolism were investigated.
Journal ArticleDOI

Cannabidiol in Anxiety and Sleep: A Large Case Series

TL;DR: A large retrospective case series involving clinical application of CBD for anxiety and sleep complaints as an adjunct to usual treatment found CBD was well tolerated in all but 3 patients.
References
More filters
Journal ArticleDOI

Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L.

TL;DR: Chemical investigation of the pollen grain collected from male plants of Cannabis sativa L. resulted in the isolation for the first time of two flavonol glycosides from the methanol extract, and the identification of 16 cannabinoids in the hexane extract.
Journal ArticleDOI

Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol☆

TL;DR: Canadian cannabichromene produced a subset of behavioral activity in the tetrad assay and reduced LPS-induced paw edema through a noncannabinoid receptor mechanism of action.
Book ChapterDOI

Hairy root cultures for secondary metabolites production

TL;DR: The present review summarizes updated aspects of the hairy root induction, genetics and metabolite production.
Journal ArticleDOI

Three phenyldihydronaphthalene lignanamides from fruits of Cannabis sativa

TL;DR: Three new lignanamides, named cannabisin B, C and D, were isolated from the fruits of Cannabis sativa and their structures have been elucidated based on spectral and chemical evidence.
Journal ArticleDOI

The inheritance of chemical phenotype in Cannabis sativa L. (III): variation in cannabichromene proportion

TL;DR: The mechanism that controls the proportion of cannabichromene (CBC), a potential pharmaceutical, in the cannabinoid fraction of Cannabis sativa L. is explored and the ability of PJC plants to enable the production of pharmaceutical raw material with high CBC purity is demonstrated.
Related Papers (5)